News & Events 2012

CTI Clinical Trial and Consulting Services Announces Multiple Office Expansions

December 14, 2012

CTI Clinical Trial and Consulting Services (CTI) announces the expansion of its offices in Cincinnati, Ohio (Global Headquarters); Raleigh, North Carolina; Madrid, Spain; and Ulm, Germany (European Headquarters). “This reflects continued growth of the company due to new business awards from our current pharmaceutical and biotechnology sponsors,” according to ...

Read More

November Newsletter - Electronic Common Technical Document (eCTD)

November 1, 2012

Read More

CTI Clinical Trial and Consulting Services Announces Kathryn Wekselman, PhD RN, Director, Regulatory and Scientific Affairs, Will Present at the 2012 Regulatory Affairs Professionals Society (RAPS) Annual Conference

October 12, 2012

CTI Clinical Trial and Consulting Services (CTI) announces that their Director, Regulatory and Scientific Affairs, Kathryn Wekselman, PhD RN will serve as a session leader at the 2012 Regulatory Affairs Professionals Society (RAPS) Annual Conference, taking place October 26-30, 2012 in Seattle. Dr. Wekselman will preside over the session “Biosimilars ...

Read More

CTI Clinical Trial and Consulting Services Announces Expanded Capabilities in Electronic Publishing and Submission of Regulatory Documents

October 5, 2012

CTI Clinical Trial and Consulting Services (CTI) announces its expanded capabilities in electronic publishing and submission of regulatory documents in partnership with Octagon Research Solutions. Using Octagon’s Quantum Submission ManagerTM and Quantum Document PublisherTM, CTI can now prepare regulatory submissions in eCTD (electronic Common Technical Document) format, which is the ...

Read More

October Newsletter - The Medicare New Technology Add-On Payment Program

October 1, 2012

Read More

September Newsletter - Special Protocol Assessments

September 1, 2012

Read More

CTI Clinical Trial and Consulting Services Announces that Kathy Wekselman has joined as a Senior Research Scientist

August 20, 2012

CTI Clinical Trial and Consulting Services announces the hiring of Kathy Wekselman as a Senior Research Scientist Kathy comes to CTI from INC Research, where she served as Director, Regulatory Strategy, Consulting, and Submissions. She was responsible for overseeing the preparation for IND, NDA, MAA and multiple other submissions. ...

Read More

August Newsletter - Orphan Drugs

August 1, 2012

Read More

CTI Clinical Trial and Consulting Services Announces Its Opening of an Office in the United Kingdom

July 26, 2012

CTI Clinical Trial and Consulting Services (CTI) announces that is has opened an office outside of London, England. The office is opened through its newly created wholly-owned subsidiary, CTI Clinical Trial and Consulting Services UK Ltd. “The new company and UK location allows CTI to continue to better serve ...

Read More

CTI Clinical Trial and Consulting Services Announces Lynn Fallon, Executive Vice President, and President, CTI Consulting, Will Present at CBI’s 5th Annual Congress on Access Programs for Investigational and Pre-Launch Drugs

July 11, 2012

Lynn Fallon will present at the CBI’s 5th Annual Congress on Access Programs for Investigational and Pre-Launch Drugs, taking place July 19-20, 2012 in Philadelphia, Pennsylvania. Ms. Fallon will present a case study, “Overcome Hurdles to Execute a Successful Expanded Access Program (EAP) – Voraxaze” on Friday, July 20th at ...

Read More

July Newsletter - Optimizing Clinical Trial Feasibility Assessments

July 1, 2012

Read More

June Newsletter - Regenerative Medicine

June 1, 2012

Read More

CTI Clinical Trial and Consulting Services Announces the Formation of a French Affiliate and Opening of Paris Office

May 25, 2012

CTI Clinical Trial and Consulting Services (CTI) announces the formation of a new, wholly-owned French subsidiary, CTI Clinical Trial and Consulting Services SARL, and the opening of an office in Paris, France. “The new company and geographic location continues our expansion throughout Western Europe, which allows us to better ...

Read More

May Newsletter - Longitudinal Data Analysis

May 1, 2012

Read More

April Newsletter - Training Resources

April 1, 2012

Read More

March Newsletter - Site Contracts

March 1, 2012

Read More

CTI Clinical Trial and Consulting Services Manages Expanded Access Program of Recently FDA Approved Drug

February 22, 2012

CTI has been involved in managing an Expanded Access Program for Voraxaze® (glucarpidase), for which BTG International Inc. recently received US Food and Drug Administration regulatory approval. The program provided emergency use of glucarpidase within 24 hours for patients with methotrexate toxicity and impaired renal function under a treatment ...

Read More

CTI Clinical Trial and Consulting Services Announces President and CEO, Timothy J. Schroeder, Will Present at 7th Annual New York Stem Cell Summit

February 15, 2012

Timothy J. Schroeder will present at the 7th Annual New York Stem Cell Summit, taking place February 21, 2012, where more than 30 of the world's leaders in this rapidly evolving industry will meet to discuss issues and opportunities in the stem cell market. Mr. Schroeder will present on the ...

Read More

CTI Clinical Trial and Consulting Services Announces Dr. William Irish to Participate in “Consensus Conference on Transplant Program Quality and Surveillance”

February 13, 2012

William Irish, PhD has been invited to participate in the “Consensus Conference on Transplant Program Quality and Surveillance” sponsored jointly by the Scientific Registry of Transplant Recipients (SRTR) and the Organ Procurement and Transplantation Network (OPTN). The program will be held February 13-15, 2012 in Arlington, Virginia. Dr. Irish, ...

Read More

CTI Clinical Trial and Consulting Services Announces that Melanie Bruno, PhD, MBA has joined as Vice President, Clinical Trial Operations

February 8, 2012

CTI Clinical Trial and Consulting Services (CTI) announces the addition of Melanie A. Bruno, PhD, MBA as Vice President, Clinical Trial Operations. Dr. Bruno comes to CTI with over 18 years of Clinical and Regulatory drug development expertise in the biopharmaceutical and clinical research industries. Dr. Bruno joins CTI ...

Read More

February Newsletter - Expanded Access Program

February 1, 2012

Read More

January Newsletter - Rescue Studies

January 1, 2012

Read More

Join Our Mailing List